Wockhardt Limited (BOM:532300)
India · Delayed Price · Currency is INR 2,013.30
+2.35 (0.12%)
At close: Jun 22, 2026
Wockhardt Revenue
In the fiscal year ending March 31, 2026, Wockhardt had annual revenue of 33.73B INR with 11.14% growth. Wockhardt had revenue of 9.65B in the quarter ending March 31, 2026, with 25.98% growth.
Revenue
33.73B
Revenue Growth
+11.14%
P/S Ratio
9.70
Revenue / Employee
14.69M
Employees
2,296
Market Cap
327.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 33.73B | 3.38B | 11.14% |
| Mar 31, 2025 | 30.35B | 2.05B | 7.24% |
| Mar 31, 2024 | 28.30B | 1.73B | 6.51% |
| Mar 31, 2023 | 26.57B | -5.73B | -17.74% |
| Mar 31, 2022 | 32.30B | 5.22B | 19.28% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 82.80B |
| Abbott India | 69.29B |
| Granules India | 53.66B |
| J. B. Chemicals & Pharmaceuticals | 41.48B |
| GlaxoSmithKline Pharmaceuticals | 38.22B |
| Viyash Scientific | 34.20B |
| AstraZeneca Pharma India | 22.76B |
| Caplin Point Laboratories | 21.87B |
Wockhardt News
- 18 hours ago - Pharma sector stocks trade mixed on June 22: Cipla up 2.23%, Indoco Remedies gains 2.38%, Wockhardt falls 1.41% - Business Upturn
- 18 hours ago - Pharma sector stocks today on June 22: Cipla up 2.23%, Indoco Remedies gains 2.38%, Wockhardt falls 1.41% - Business Upturn
- 4 days ago - Pharma sector stocks rises today, June 18: Wockhardt up 2.86%, Natco Pharma gains 2.38%, Panacea Biotech rises 2.01% - Business Upturn
- 10 days ago - Pharma sector stocks rise today, June 12: Panacea Biotech gains 2.50%, Wockhardt rises 2.24%, Natco Pharma up 1.36% - Business Upturn
- 11 days ago - Top gainers in morning trade: aegis logistics at ₹891.50 up 11.30%, wockhardt at ₹1,927.00 up 5.13%, DOMS industries at ₹2,219.90 up 4.78% - Business Upturn
- 11 days ago - Pharma sector stocks surge today, June 11: Wockhardt up 2.41%, Strides Pharma gains 2.10%, Indoco Remedies rises 2.58% - Business Upturn
- 12 days ago - Pharma sector stocks today, June 10: Panacea Biotech falls 8.09%, Wockhardt declines 1.47%, Alembic Pharma up 1.02% - Business Upturn
- 17 days ago - Top losers today: wockhardt at ₹1,920.90 down 7.33%, gujarat state petronet at ₹268.35 falls 7.13%, hindustan zinc at ₹566.80 slips 6.14% - Business Upturn